Pfizer in talks to buy cancer drugmaker Seagen in $30B deal

(Reuters) - Pfizer Inc. is in early-stage talks to acquire cancer drugmaker Seagen Inc in what could be a multi-billion dollar deal, The Wall Street Journal reported, citing people familiar with the matter.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...